Benefit of adjuvant chemotherapy in patients with lobular breast cancer: A systematic review of the literature and metanalysis
出版年份 2021 全文链接
标题
Benefit of adjuvant chemotherapy in patients with lobular breast cancer: A systematic review of the literature and metanalysis
作者
关键词
Lobular breast cancer, Adjuvant chemotherapy, Lobular cancer, Benefit of treatments, Early breast cancer
出版物
CANCER TREATMENT REVIEWS
Volume 97, Issue -, Pages 102205
出版商
Elsevier BV
发表日期
2021-04-09
DOI
10.1016/j.ctrv.2021.102205
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The 2019 WHO classification of tumours of the breast
- (2020) Puay Hoon Tan et al. HISTOPATHOLOGY
- E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
- (2020) Matthias Christgen et al. MODERN PATHOLOGY
- How to treat lobular cancer in the adjuvant setting?
- (2020) Dario Trapani et al. CURRENT OPINION IN ONCOLOGY
- CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?
- (2020) Antonio C. Wolff JOURNAL OF CLINICAL ONCOLOGY
- Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- (2020) Stephen R. D. Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study
- (2020) Richard Buus et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit
- (2019) Alexandre de Nonneville et al. BREAST CANCER RESEARCH AND TREATMENT
- Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
- (2019) H J Burstein et al. ANNALS OF ONCOLOGY
- Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial
- (2019) J M S Bartlett et al. ANNALS OF ONCOLOGY
- Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
- (2019) Aleix Prat et al. LANCET ONCOLOGY
- CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
- (2019) Jennifer J Gao et al. LANCET ONCOLOGY
- 21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer
- (2018) Xiang-Hong Chen et al. Biomarkers in Medicine
- Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade
- (2018) Otto Metzger‐Filho et al. ONCOLOGIST
- Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer
- (2017) Masayuki Inoue et al. Breast Cancer
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Treatment choices for patients with invasive lobular breast cancer: a doctor survey
- (2015) Carmel Jacobs et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
- (2013) Y Delpech et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
- (2013) Y. Zhang et al. CLINICAL CANCER RESEARCH
- Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer
- (2012) W. Truin et al. ANNALS OF ONCOLOGY
- Invasive lobular breast cancer: subtypes and outcome
- (2012) Monica Iorfida et al. BREAST CANCER RESEARCH AND TREATMENT
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Survival of breast cancer patients with meningeal carcinomatosis
- (2010) H. Gauthier et al. ANNALS OF ONCOLOGY
- The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
- (2009) Britta Weigelt et al. JOURNAL OF PATHOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast
- (2008) Leonard Da Silva et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials
- (2008) Bernhard C. Pestalozzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
- Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
- (2007) Emad A. Rakha et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started